Susquehanna International Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,059
| Closed | -$8.57M | – | 6669 |
|
|
2023
Q2 | $8.57M | Sell |
84,059
-17,811
| -17% | -$1.82M | ﹤0.01% | 778 |
|
|
2023
Q1 | $9.26M | Buy |
101,870
+86,819
| +577% | +$7.89M | ﹤0.01% | 774 |
|
|
2022
Q4 | $572K | Buy |
15,051
+6,628
| +79% | +$252K | ﹤0.01% | 3020 |
|
|
2022
Q3 | $212K | Buy |
+8,423
| New | +$212K | ﹤0.01% | 4720 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6947 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6776 |
|
|
2021
Q4 | – | Sell |
-5,096
| Closed | -$513K | – | 6637 |
|
|
2021
Q3 | $513K | Buy |
5,096
+731
| +17% | +$73.6K | ﹤0.01% | 3675 |
|
|
2021
Q2 | $618K | Sell |
4,365
-75,333
| -95% | -$10.7M | ﹤0.01% | 3625 |
|
|
2021
Q1 | $7.95M | Buy |
79,698
+48,107
| +152% | +$4.8M | ﹤0.01% | 925 |
|
|
2020
Q4 | $3.91M | Sell |
31,591
-60,130
| -66% | -$7.43M | ﹤0.01% | 1186 |
|
|
2020
Q3 | $8.94M | Buy |
91,721
+33,833
| +58% | +$3.3M | ﹤0.01% | 581 |
|
|
2020
Q2 | $9.03M | Buy |
57,888
+31,562
| +120% | +$4.92M | ﹤0.01% | 566 |
|
|
2020
Q1 | $3.8M | Sell |
26,326
-37,352
| -59% | -$5.39M | ﹤0.01% | 852 |
|
|
2019
Q4 | $13M | Buy |
63,678
+31,665
| +99% | +$6.47M | ﹤0.01% | 433 |
|
|
2019
Q3 | $2.57M | Buy |
32,013
+23,795
| +290% | +$1.91M | ﹤0.01% | 1040 |
|
|
2019
Q2 | $775K | Buy |
+8,218
| New | +$775K | ﹤0.01% | 2403 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4846 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5138 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4984 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4970 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4770 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4704 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4461 |
|